An unknown buyer agreed to acquire AdhereRx Incorporated from Optimus Healthcare Services, Inc. for approximately $3 million on December 7, 2022. agreed to exchange 100% of the outstanding shares of PainScript for 1,600,000 shares of the Company's common stock. The transactions contemplated by the Agreement closed on December 15, 2022. In connection with the closing of the Agreement, the 400,000 earnout shares issued to the former shareholders of PainScript were also cancelled. In addition, at closing, the Company provided a loan in the aggregate principal amount of $200,000 to PainScript to cover employee liabilities and general working capital. The loan bears interest at a rate of 8% per annum and matures on the one year anniversary of the original issuance date. The loan is secured by a pledge of a majority of the voting capital stock of PainScript held by certain PainScript shareholders. The Company also contributed $100,000 to PainScript in order to cover outstanding liabilities.

An unknown buyer completed the acquisition of AdhereRx Incorporated from Optimus Healthcare Services, Inc. for approximately $3 million on December 15, 2022.